Balmer, A.; Clerc, D.; Toussaint, L.; Sgarbura, O.; Taïbi, A.; Hübner, M.; Teixeira Farinha, H.
Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases. Cancers 2022, 14, 2557.
https://doi.org/10.3390/cancers14102557
AMA Style
Balmer A, Clerc D, Toussaint L, Sgarbura O, Taïbi A, Hübner M, Teixeira Farinha H.
Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases. Cancers. 2022; 14(10):2557.
https://doi.org/10.3390/cancers14102557
Chicago/Turabian Style
Balmer, Aurélie, Daniel Clerc, Laura Toussaint, Olivia Sgarbura, Abdelkader Taïbi, Martin Hübner, and Hugo Teixeira Farinha.
2022. "Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases" Cancers 14, no. 10: 2557.
https://doi.org/10.3390/cancers14102557
APA Style
Balmer, A., Clerc, D., Toussaint, L., Sgarbura, O., Taïbi, A., Hübner, M., & Teixeira Farinha, H.
(2022). Selection Criteria for Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatment in Patients with Peritoneal Metastases. Cancers, 14(10), 2557.
https://doi.org/10.3390/cancers14102557
